Study of the Anticancer Potential of Plant Extracts Using Liver Tumor Microphysiological System

Abstract

Background: Plants have been considered a vital source of modern pharmaceutics since the paleolithic age. Contemporary chemotherapeutic drugs for cancer therapy are chemical entities sourced from plants. However, synthetic drugs or their derivatives come with severe to moderate side effects for human health. Hence, the quest to explore and discover plant-based novel anticancer drugs is ongoing. Anticancer activities are the primary method to estimate the potential and efficacy of an extract or compound for drug discovery. However, traditional in vitro anticancer activity assays often show poor efficacy due to the lack of in-vivo-like cellular environment. In comparison, the animal-based in vivo assays lack human genetic makeup and have ethical concerns. Aim: This study aimed to overcome the limitations of traditional cell-culture-based anticancer assays and find the most suitable assay for anticancer activity of plant extracts. We first reported utilizing a liver tumor microphysiological system in the anticancer effect assessment of plant extracts. Methodology: Methanolic extracts of Acer cappadocicum Gled were used to assess anticancer activity against liver tumor microphysiological system (MPS), and cell viability, liver function tests, and antioxidant enzyme activities were performed. Additionally, an embedded transepithelial electrical resistance sensor was utilized for the real-time monitoring of the liver tumor MPS. The results were also compared with the traditional cell culture model. Results: The study demonstrated the superiority of the TEER sensor-based liver tumor MPS by its better anticancer activity based on cell viability and biomarker analysis compared to the traditional in vitro cell culture model. The anticancer effects of the plant extracts were successfully observed in real time, and methanolic extracts of Acer cappadocicum Gled increased the alanine transaminase and aspartate aminotransferase secretion, which may reveal the different mechanisms of these extracts and suggest a clue for the future molecular study of the anticancer pathways. Conclusion: Our results show that the liver tumor microphysiological system could be a better platform for plant-based anticancer activity assessment than traditional cell culture models.

Choroidal Thickness in Different Patterns of Diabetic Macular Edema

“…For the quantitative variable, the normality assumption was evaluated by using the Shapiro–Wilk and Kolmogorov–Smirnov tests. ANOVA and independent-sample t -test were applied to compare choroidal thickness in diffuse and focal groups, and a post hoc test was performed for inter-group comparisons [ 31 , 32 ]. The p -value of ≤0.05 was considered significant.…”

Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes

“…It mainly involves the growth of cells in an artificial environment composed of an appropriate surface and nutrient supply. , Usually, cells are grown in in vitro models for days or weeks in a sterile environment. These in vitro models allow the study of the cellular response to potential drugs. − Numerous cell lines have been used in 2D and 3D in vitro models, e.g., human colon carcinoma cell (Caco-2) is commonly used to determine the absorption of drug candidates. Caco-2 cells are used because they form a tight junction in a 2D monolayer in vitro model, miming intestinal epithelium that implies drug transport, making them an explicit model for testing drug absorption .…”

“…Furthermore, OOC systems can be integrated with traditional analytical techniques, such as high-throughput screening systems, automated imaging systems, and molecular analysis, to provide comprehensive insights into the molecular mechanisms underlying the effects of nutraceuticals. This can aid in identifying biomarkers, elucidating cellular signaling pathways, and optimizing the formulation and delivery of nutraceuticals. ,,, …”

“…This can aid in identifying biomarkers, elucidating cellular signaling pathways, and optimizing the formulation and delivery of nutraceuticals. 12,13,36,42 The OOC model involves the use of cell culture on ECMloaded biocompatible membranes, which is subjected to physical and electrical signals through sensors, and microfluidic channels to induce physiological shear stress and simulate the in vivo microenvironment. These physical signals are generated through dynamic flow, microfluidics-based channels, and sensors, i.e., transepithelial electrical resistance (TEER) sensors which can be integrated into the OOC model to monitor and control the cellular microenvironment and provide noninvasive results and improved consistency of tissue structures for study of organ-level function for nutraceutical testing and drug discovery.…”

Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery

“…For example, variations in flow rate and pressure can affect the shear stress experienced by cells in microfluidic channels, which can in turn influence their behavior and function. Similarly, surface tension and wettability can impact the adhesion and migration of cells within microfluidic devices, which is important for studying processes such as angiogenesis and tumor metastasis ( Tovar-Lopez et al, 2019 ; Kausar et al, 2021 ; Farooqi et al, 2022 ; Kausar et al, 2022 ). These parameters enable the selection of appropriate materials, cell types, and culture conditions to ensure optimal organ functionality and accurate disease modeling ( Ahmed et al, 2022a ; Ahmed, 2022 ).…”